Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated grew its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 37.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,686 shares of the medical instruments supplier’s stock after purchasing an additional 1,544 shares during the quarter. Silver Oak Securities Incorporated’s holdings in Merit Medical Systems were worth $549,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of MMSI. USA Financial Formulas acquired a new position in Merit Medical Systems during the third quarter worth about $59,000. Farther Finance Advisors LLC boosted its holdings in shares of Merit Medical Systems by 32.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in shares of Merit Medical Systems during the 3rd quarter worth approximately $120,000. GAMMA Investing LLC increased its holdings in shares of Merit Medical Systems by 56.8% in the third quarter. GAMMA Investing LLC now owns 1,303 shares of the medical instruments supplier’s stock valued at $129,000 after purchasing an additional 472 shares during the last quarter. Finally, TD Private Client Wealth LLC lifted its position in Merit Medical Systems by 13.9% during the third quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock worth $171,000 after buying an additional 211 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Insider Buying and Selling

In other news, Director F. Ann Millner sold 12,500 shares of the stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $101.55, for a total transaction of $1,269,375.00. Following the sale, the director now owns 32,391 shares of the company’s stock, valued at approximately $3,289,306.05. This represents a 27.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Needham & Company LLC upped their target price on Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $127.00 to $128.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Robert W. Baird lifted their target price on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a research note on Thursday, October 31st. StockNews.com cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Finally, Barrington Research lifted their price target on shares of Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a research report on Wednesday, January 29th. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $109.80.

Merit Medical Systems Stock Up 0.1 %

NASDAQ:MMSI opened at $109.12 on Friday. Merit Medical Systems, Inc. has a 52 week low of $70.70 and a 52 week high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The stock’s fifty day moving average is $101.88 and its two-hundred day moving average is $97.91. The stock has a market capitalization of $6.36 billion, a price-to-earnings ratio of 53.49, a price-to-earnings-growth ratio of 2.41 and a beta of 0.87.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.